Expression of genes encoding extracellular matrix proteins: a macroarray study.

Area of Science:

• Oncology
• Molecular Biology
• Gynecologic Oncology

Background:

• Endometrial cancer (EC) is a prevalent gynecological malignancy in Poland.
• Understanding the molecular basis of endometrial carcinogenesis is crucial for targeted therapies.
• Genetic instability and molecular alterations are key factors in EC development.

Purpose of the Study:

• To investigate gene expression profiles of extracellular matrix (ECM) proteins in endometrial cancer (EC).
• To compare ECM protein gene expression between normal endometrial tissues and EC specimens.
• To analyze expression differences stratified by the clinical stage of EC.

Main Methods:

• Utilized cDNA macroarrays to analyze gene expression profiles.
• Collected tissue specimens from 40 EC patients and 9 control patients with uterine leiomyomas.
• Isolated RNA and performed RT-PCR with radioisotope-labeled cDNA for gene expression analysis.

Main Results:

• Detected statistically significant differences in gene expression for aggrecan, vitronectin, tenascin R, nidogen, collagen type VIII chain α1, and collagen type XI chain α2.
• Observed overexpression of these ECM proteins in stage III EC compared to stages I and II.
• Highlighted differential gene expression patterns correlating with EC clinical stage.

Conclusions:

• Increased expression of genes encoding ECM proteins is associated with endometrial cancer.
• These ECM protein alterations may contribute to accelerated disease progression in EC.
• Findings provide insights into the molecular mechanisms underlying EC development and progression.